Insightec announced today that it received additional FDA approval for treating essential tremor with its Exablate Neuro platform. Essential tremor commonly affects both sides of the body, Insightec noted in a news release. The new approval allows appropriate patients to receive treatment on their second side at least nine months after treatment of the first […]
Fujifilm to acquire Inspirata’s digital pathology business
Fujifilm announced today that it entered into an asset purchase agreement for the global digital pathology business of Inspirata. Upon completing the agreement, Fujifilm absorbs Inspirata’s Dynamyx digital pathology technology. Additionally, it takes on employees and customers of the company. Fujifilm expects to complete the transaction in early 2023. Terms of the agreement have not […]
Embecta stock slides on mixed Q4 results
Embecta (Nasdaq:EMBC) shares dipped before the market opened today on fourth-quarter results that came in mixed compared to the consensus forecast. EMBC shares fell more than 12% to $29.73 apiece in morning trading. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up more than 4%. The Parsippany, New Jersey-based […]
Amalgam Rx, Novo Nordisk expand partnership on connected insulin delivery devices
Amalgam Rx announced today that it expanded its global agreement with Novo Nordisk over the commercialization of Dose Check. Wilmington, Delaware-based Amalgam Rx develops the Dose Check digital insulin initiation and titration app. It designed the app to help people with type 2 diabetes using basal insulin. The two companies partnered to incorporate and integrate […]
Artificial heart developer Carmat could receive up to €17.5M in funding
Carmat announced today that the European Council selected it to join its EIC Accelerator program for innovative companies in Europe. The total funding could reach €17.5 million ($18.6 million). Paris-based Carmat develops a total artificial heart. It designed the platform to provide a therapeutic alternative for those suffering from end-stage biventricular heart failure. EIC Accelerator […]
Butterfly Network deploys 500 Butterfly iQ+ devices in Kenya
Butterfly Network (NYSE:BFLY) announced today that it completed the first phase of its deployment and training program in Kenya. In March, Butterfly Network announced a $5 million grant to improve maternal and fetal health in Sub-Saharan Africa. The Bill & Melinda Gates Foundation provided the grant. The funds went toward providing 1,000 healthcare workers in the area with […]
FDA approves implantable rechargeable spinal cord stimulation system from Abbott
Abbott (NYSE:ABT) announced today that the FDA approved its Eterna spinal cord stimulation (SCS) system. Eterna is an implantable, rechargeable SCS system. It offers treatment for chronic pain. Abbott said in a news release that Eterna represents the smallest such SCS system on the market for that indication. The system uses Abbott’s proprietary low-dose BurstDR […]
Cardinal Health names new CFO
Cardinal Health (NYSE:CAH) announced today that it appointed Aaron Alt as its new chief financial officer (CFO). Alt succeeds interim CEO Trish English, reporting to CEO Jason Hollar. He also joins Cardinal Health’s executive committee, effective Feb. 10, 2023. Hollar previously served as CFO before taking over the corner office at Cardinal Health in September. […]
Staar Surgical CEO Caren Mason retires, replacement named
Staar Surgical (Nasdaq:STAA) announced today that President and CEO Caren Mason intends to retire at the end of the year. Mason plans to retire on Dec. 31, 2022 from Staar, a creator of implantable lenses for the eye and companion delivery systems. Staar Surgical’s board appointed ophthalmic industry executive Thomas G. Frinzi — a veteran […]
J&J’s Auris alleges former employees brought trade secrets to new company Noah Medical
Johnson & Johnson‘s Auris Health surgical robotics business filed litigation this week alleging misappropriation of trade secrets by Noah Medical. In its complaint filed in U.S. District Court in Northern California, Auris alleges “shameless, systematic and ongoing misappropriation of trade secrets” by Noah. It named former Auris employees Enrique Romo, Diana Cardona Ujueta and Kenneth […]
Click Therapeutics wins FDA breakthrough nod for migraine-treating digital therapeutic
Click Therapeutics announced today that it received FDA breakthrough device designation for its CT-132 prescription digital therapeutic (PDT). New York-based Click designed CT-132 as an adjunctive preventive treatment for episodic migraine in patients 18 years old and up. “We are thrilled to receive this Breakthrough designation as it will facilitate collaborative discussions with the FDA […]